1/14
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
indications for neonatal/pediatric oxygen therapy
treat/prevent hypoxemia
support metabolism and tissue oxygenation
neonates: SpO2 below target range, WOB, cyanosis, apnea
infants/kids: SpO2 < 92-94% with distress, acute/chronic lung disease, trauma, CHD, shock
disease-specific applications of oxygen therapy
neonates
RDS
transient tachypnea of the newborn (TTN)
meconium aspiration syndrome (MAS)
pneumonia
disease-specific applications of oxygen therapy
bronchopulmonary dysplasia (BPD)
long-term O2
risk of CO2 retention
disease-specific applications of oxygen therapy
pediatrics
asthma: O2 during attacks
bronchiolitis: O2, HFNC
CHD: avoid hyperoxia in duct-dependent lesions
developmental respiratory physiology
fetal Hb: high O2 affinity
immature lungs: low CL, high closing volumes
preterm: limited antioxidants, more vulnerable to O2 toxicity
manifestations of hypoxemia
respiratory: tachypnea, grunting, retractions
CV: brady-/tachycardia, poor perfusion
neuro: irritability, poor feeding
target SpO2 ranges
neonates: 90-95% (avoid prolonged > 97%)
preterm: 88-94%
kids: ≥ 92%
pediatric oxygen principles
start low, go slow
pre-/postductal monitoring
continuous monitoring and humidity
pediatric O2 devices
nasal cannula
mask
HFNC
hoods/incubators (neonates)
estimating and managing pediatric FiO2
NC: ~4% FiO2 increase per L/min
variable vs. fixed FiO2
O2 analyzer
choosing right pediatric O2 delivery system
based on age, comfort, condition
indications for heated high-flow nasal cannula (HHFNC)
hypoxemia and mild to moderate respiratory distress
usually used in the ED and ICU
hazards of HHFNC
can’t measure distending pressures
needs electricity to work
hazards of O2 therapy
retinopathy of prematurity (ROP)
avoid SpO2 > 95%
O2 toxicity: lung injury
absorption atelectasis
CO2 retention (BPD)
O2 monitoring and documentation
alarms
continuous SpO2
O2 analyzer
weaning: decrease FiO2 in 2-5% steps